Icatibant Acetate
| Catalog No. | KMI019003 |
|---|---|
| CAS No. | 138614-30-9 |
| Formula | C59H89N19O13S : C2H4O2 |
| FW | 1304.5 : 60.1 |
| Unit | Price | Stock |
|---|---|---|
| 100 mg | Enquire | Enquire |
| Chemical Name: | ((2S,3aS,7aS)-1-((R)-2-(((S)-2-(2-((2S,4R)-1-(D-Arginyl-L-arginyl-L-prolyl)-4-hydroxypyrrolidine-2-carboxamido)acetamido)-3-(thiophen-2-yl)propanoyl)-L-seryl)-1,2,3,4-tetrahydroisoquinoline-3-carbonyl)octahydro-1H-indole-2-carbonyl)-L-arginine compound with acetic acid (1:1) |
|---|---|
| Purity: | >95% |
| Storage: | Store at 2-8 deg. C for long term storage |
| Shipping: | Product is stable to be Shipped at Room Temperature |
Icatibant Acetate is chemically ((2S,3aS,7aS)-1-((R)-2-(((S)-2-(2-((2S,4R)-1-(D-Arginyl-L-arginyl-L-prolyl)-4-hydroxypyrrolidine-2-carboxamido)acetamido)-3-(thiophen-2-yl)propanoyl)-L-seryl)-1,2,3,4-tetrahydroisoquinoline-3-carbonyl)octahydro-1H-indole-2-carbonyl)-L-arginine compound with acetic acid (1:1) .
Icatibant Acetate is supplied with detailed characterization data compliant with regulatory guideline.
Icatibant Acetate can be used for the analytical method development, method validation (AMV), Quality Controlled (QC)
application for Abbreviated New Drug Application (ANDA) or during commercial production of Icatibant Acetate.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. K.M.Pharma products are for analytical purpose only and not for human use.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. K.M.Pharma products are for analytical purpose only and not for human use.
Related Products
CAT No: KMI019001
CAT No: KMI019002
CAT No: KMI019004
CAT No: KMI019005
CAT No: KMI019006
CAT No: KMI019007
CAT No: KMI019008
CAT No: KMI019009
CAT No: KMI019010
CAT No: KMI019011
CAT No: KMI019012
CAT No: KMI019013
CAT No: KMI019014
CAT No: KMI019015
CAT No: KMI019016